| Autor: |
Smith, D., Wiegeshaus, E., Balasubramanian, V. |
| Předmět: |
|
| Zdroj: |
Clinical Infectious Diseases; 9/1/2000 Supplement 4, Vol. 31, pS68, 3p |
| Abstrakt: |
Discusses the evolution of animal models for tuberculosis vaccine assays through a series of sequential experiments aimed at optimizing the activity of a particular vaccine product. Ways in which an investigator can show that any given vaccine product has superior potency; Need for attention on animal models that replicate the key aspects of the natural history of human tuberculosis. |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
